ranolazine has been researched along with Acute Kidney Failure in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bu, P; Chen, T; Liu, L; Ma, C; Qi, Y; Ti, Y; Yang, Y; Zhang, C | 1 |
| Gitman, M; Hazzan, A; Jhaveri, KD; Patni, H | 1 |
2 other study(ies) available for ranolazine and Acute Kidney Failure
| Article | Year |
|---|---|
Ranolazine alleviates contrast-associated acute kidney injury through modulation of calcium independent oxidative stress and apoptosis.
Topics: Acute Kidney Injury; Animals; Apoptosis; Blood Urea Nitrogen; Calcium; Contrast Media; Creatinine; Disease Models, Animal; Hepatitis A Virus Cellular Receptor 1; Kidney; Lipocalin-2; Male; Mice; Mice, Inbred C57BL; Oxidative Stress; Ranolazine; Renal Artery | 2021 |
Ranolazine, tacrolimus, and diltiazem might be a hazardous combination in a transplant patient.
Topics: Acetanilides; Acute Kidney Injury; Calcium Channel Blockers; Diltiazem; Drug Interactions; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Piperazines; Postoperative Complications; Ranolazine; Tacrolimus | 2012 |